13603-25-3,MFCD03426127
Catalog No.:AA009AX8

13603-25-3 | 3-Benzylpiperidine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
96%
in stock  
$31.00   $22.00
- +
250mg
96%
in stock  
$75.00   $53.00
- +
1g
98%(GC)
in stock  
$226.00   $158.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA009AX8
Chemical Name:
3-Benzylpiperidine
CAS Number:
13603-25-3
Molecular Formula:
C12H17N
Molecular Weight:
175.2701
MDL Number:
MFCD03426127
SMILES:
C1CCC(CN1)Cc1ccccc1
Properties
Computed Properties
 
Complexity:
138  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
13  
Hydrogen Bond Acceptor Count:
1  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0  
Rotatable Bond Count:
2  
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0  
XLogP3:
2.5  

Downstream Synthesis Route

[1]CurrentPatentAssignee:Novartis(w/oSandoz);NOVARTISAG-WO2013/102242,2013,A1Locationinpatent:Page/Pagecolumn93

[2]Ablordeppey,SethY;Fischer,JamesB;Law;Glennon,RichardA[Bioorganicandmedicinalchemistry,2002,vol.10,#8,p.2759-2765]

[3]Liu,Zhi-Yun;Wen,Zhi-Hui;Wang,Xiao-Chen[AngewandteChemie-InternationalEdition,2017,vol.56,#21,p.5817-5820][Angew.Chem.,2017,vol.129,p.5911-5914,4]

[4]Tschitschibabin[ChemischeBerichte,1903,vol.36,p.2711]

[5]CurrentPatentAssignee:SANOFI-US4069256,1978,ACurrentPatentAssignee:SANOFI-US4216326,1980,ACurrentPatentAssignee:SANOFI-US4308382,1981,A

[1]Walters;McElvain[JournaloftheAmericanChemicalSociety,1933,vol.55,p.4625,4626]

[2]Tschitschibabin[ChemischeBerichte,1903,vol.36,p.2711]

[1]Ding,CharlesZ.;Rovnyak,GeorgeC.;Misra,RajN.;Grover,GaryJ.;Miller,ArthurV.;Ahmed,SyedZ.;Kelly,Yolanda;Normandin,DianeE.;Sleph,PaulG.;Atwal,KarnailS.[JournalofMedicinalChemistry,1999,vol.42,#18,p.3711-3717]

13603-25-3    14469-83-1   
1-(5-Phenylpentyl)-3-benzylpiperidine 

[1]Ablordeppey,SethY;Fischer,JamesB;Law;Glennon,RichardA[Bioorganicandmedicinalchemistry,2002,vol.10,#8,p.2759-2765]

Literature

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters 20101101

Title: From rigid cyclic templates to conformationally stabilized acyclic scaffolds. Part II: Acyclic replacements for the (3S)-3-benzylpiperidine in a series of potent CCR3 antagonists.

Journal: Bioorganic & medicinal chemistry letters 20080115

Title: Discovery of CC chemokine receptor-3 (CCR3) antagonists with picomolar potency.

Journal: Journal of medicinal chemistry 20050324

Title: Discovery of N-propylurea 3-benzylpiperidines as selective CC chemokine receptor-3 (CCR3) antagonists.

Journal: Bioorganic & medicinal chemistry letters 20040405

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:13603-25-3 Molecular Formula|13603-25-3 MDL|13603-25-3 SMILES|13603-25-3 3-Benzylpiperidine
Catalog No.: AA009AX8
13603-25-3,MFCD03426127
13603-25-3 | 3-Benzylpiperidine
Pack Size: 100mg
Purity: 96%
in stock
$31.00 $22.00
Pack Size: 250mg
Purity: 96%
in stock
$75.00 $53.00
Pack Size: 1g
Purity: 98%(GC)
in stock
$226.00 $158.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA009AX8
Chemical Name: 3-Benzylpiperidine
CAS Number: 13603-25-3
Molecular Formula: C12H17N
Molecular Weight: 175.2701
MDL Number: MFCD03426127
SMILES: C1CCC(CN1)Cc1ccccc1
Properties
Complexity: 138  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 13  
Hydrogen Bond Acceptor Count: 1  
Hydrogen Bond Donor Count: 1  
Isotope Atom Count: 0  
Rotatable Bond Count: 2  
Undefined Atom Stereocenter Count: 1  
Undefined Bond Stereocenter Count: 0  
XLogP3: 2.5  
Downstream Synthesis Route
620-95-1    13603-25-3 

[1]CurrentPatentAssignee:Novartis(w/oSandoz);NOVARTISAG-WO2013/102242,2013,A1Locationinpatent:Page/Pagecolumn93

[2]Ablordeppey,SethY;Fischer,JamesB;Law;Glennon,RichardA[Bioorganicandmedicinalchemistry,2002,vol.10,#8,p.2759-2765]

[3]Liu,Zhi-Yun;Wen,Zhi-Hui;Wang,Xiao-Chen[AngewandteChemie-InternationalEdition,2017,vol.56,#21,p.5817-5820][Angew.Chem.,2017,vol.129,p.5911-5914,4]

[4]Tschitschibabin[ChemischeBerichte,1903,vol.36,p.2711]

[5]CurrentPatentAssignee:SANOFI-US4069256,1978,ACurrentPatentAssignee:SANOFI-US4216326,1980,ACurrentPatentAssignee:SANOFI-US4308382,1981,A

5424-19-1    13603-25-3 

[1]Walters;McElvain[JournaloftheAmericanChemicalSociety,1933,vol.55,p.4625,4626]

[2]Tschitschibabin[ChemischeBerichte,1903,vol.36,p.2711]

13603-25-3    185316-64-7    1026916-01-7 

[1]Ding,CharlesZ.;Rovnyak,GeorgeC.;Misra,RajN.;Grover,GaryJ.;Miller,ArthurV.;Ahmed,SyedZ.;Kelly,Yolanda;Normandin,DianeE.;Sleph,PaulG.;Atwal,KarnailS.[JournalofMedicinalChemistry,1999,vol.42,#18,p.3711-3717]

13603-25-3    14469-83-1   
1-(5-Phenylpentyl)-3-benzylpiperidine 

[1]Ablordeppey,SethY;Fischer,JamesB;Law;Glennon,RichardA[Bioorganicandmedicinalchemistry,2002,vol.10,#8,p.2759-2765]

Literature fold

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters20101101

Title: From rigid cyclic templates to conformationally stabilized acyclic scaffolds. Part II: Acyclic replacements for the (3S)-3-benzylpiperidine in a series of potent CCR3 antagonists.

Journal: Bioorganic & medicinal chemistry letters20080115

Title: Discovery of CC chemokine receptor-3 (CCR3) antagonists with picomolar potency.

Journal: Journal of medicinal chemistry20050324

Title: Discovery of N-propylurea 3-benzylpiperidines as selective CC chemokine receptor-3 (CCR3) antagonists.

Journal: Bioorganic & medicinal chemistry letters20040405

Building Blocks More >
12236-29-2
12236-29-2
DisperseYellow39
AA009B5B | MFCD17214348
141263-02-7
141263-02-7
Ethyl 2,3,6-tri-O-benzyl-1-thio-b-D-glucopyranoside
AA009BHY | MFCD13182350
1252003-15-8
1252003-15-8
Tubastatin a
AA009BML | MFCD18071463
128008-87-7
128008-87-7
2-NITROFLUORENE-D9
AA009BQU | MFCD01074334
1217740-96-9
1217740-96-9
Boc-(+/-)-trans-4-(3-methoxy-phenyl)-pyrrolidine-3-carboxylic acid
AA009C0J | MFCD06659302
1421373-62-7
1421373-62-7
Mutant EGFR inhibitor
AA009CAT | MFCD28167737
1215085-93-0
1215085-93-0
GLPG0492 R-Enantiomer
AA009CF9 | MFCD28900698
1269055-85-7
1269055-85-7
Mut056399
AA009CI8 | MFCD25977011
132350-33-5
132350-33-5
1-hydroxy-4-Methylpentan-3-one
AA009CTL | MFCD22375410
134130-19-1
134130-19-1
4,4'-BIS(4-TRIFLUOROVINYLOXY)BIPHENYL
AA009D9W | MFCD04038398
Submit
© 2017 AA BLOCKS, INC. All rights reserved.